(Q41096860)

26 September 2017

1 reference

title

Clinical pharmacokinetics of zopiclone (English)

1 reference

26 September 2017

1 reference

C Fernandez

1

1 reference

26 September 2017

C Martin

series ordinal

2

1 reference

26 September 2017

F Gimenez

series ordinal

3

1 reference

26 September 2017

R Farinotti

series ordinal

4

1 reference

26 September 2017

publication date

1 December 1995

1 reference

Clinical Pharmacokinetics

26 September 2017

published in

1 reference

26 September 2017

volume

29

1 reference

26 September 2017

issue

6

1 reference

26 September 2017

page(s)

431-441

1 reference

The effect of posture at the time of administration on the central depressant effects of the new hypnotic zopiclone

26 September 2017

cites work

1 reference

12 December 2020

Pharmacokinetics and metabolism of zopiclone

1 reference

12 December 2020

Determination of zopiclone in plasma by liquid chromatography with application to steady-state monitoring

1 reference

12 December 2020

Preparative and analytical separation of the zopiclone enantiomers and determination of their affinity to the benzodiazepine receptor binding site.

1 reference

12 December 2020

Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease

1 reference

12 December 2020

Determination of zolpidem and zopiclone in serum by capillary column gas chromatography

1 reference

12 December 2020

Determination of the enantiomers of zopiclone and its two chiral metabolites in urine using an automated coupled achiral-chiral chromatographic system

1 reference

12 December 2020

Determination of zopiclone enantiomers in plasma by liquid chromatography using a chiral cellulose carbamate column

1 reference

12 December 2020

Comparison of zopiclone pharmacokinetics in patients with impaired renal function and normal subjects. Effect of hemodialysis

1 reference

12 December 2020

Interactions and comparative effects of zopiclone, diazepam and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers

1 reference

12 December 2020

Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteers

1 reference

12 December 2020

Simultaneous determination of zopiclone and its two major metabolites (N-oxide and N-desmethyl) in human biological fluids by reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

Gas chromatographic determination of zopiclone in plasma after solid-phase extraction

1 reference

12 December 2020

Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency

1 reference

12 December 2020

The effects of low and moderate doses of alcohol on the pharmacokinetic parameters of zopiclone

1 reference

12 December 2020

Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors

1 reference

12 December 2020

Development of a method for the determination of zopiclone in whole blood

1 reference

12 December 2020

Zopiclone poisoning: tissue distribution and potential for postmortem diffusion

1 reference

12 December 2020

Identification and quantification in plasma of zopiclone by gas chromatography with nitrogen-phosphorus detection

1 reference

12 December 2020

The excretion of zopiclone into breast milk

1 reference

12 December 2020

Simple and sensitive method for monitoring zopiclone in plasma by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic

1 reference

12 December 2020

Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.

1 reference

12 December 2020

Brain Receptors and Zopiclone

1 reference

12 December 2020

Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failure.

1 reference

12 December 2020

A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone (Imovane)

1 reference

12 December 2020

Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests

1 reference

12 December 2020

High-performance liquid chromatographic assay with diode-array detection for toxicological screening of zopiclone, zolpidem, suriclone and alpidem in human plasma

1 reference

12 December 2020

Stereospecific high-performance liquid chromatographic assay of zopiclone in human plasma

1 reference

12 December 2020

Drug-alcohol interactions on psychomotor skills: zopiclone and flunitrazepam.

1 reference

12 December 2020

The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone

1 reference

12 December 2020

Screening, identification and determination of the two new hypnotics zolpidem and zopiclone.

1 reference

12 December 2020

Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone

1 reference

12 December 2020

Determination of zopiclone in plasma using column liquid chromatography with ultraviolet detection

1 reference

12 December 2020

Enantioselective determination of zopiclone and its metabolites in urine by capillary electrophoresis

1 reference

12 December 2020

10.2165/00003088-199529060-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

26 September 2017

1002670249

0 references

1 reference